The expert spoke about the prospects of treating blindness with the help of light
Optogenetics, which makes it possible to control cell activity using light, may become the basis for new treatments for blindness and other diseases. Irina Zakharova, Candidate of Biological Sciences, Head of the Scientific and Educational Laboratory of Regenerative Biotechnologies and Tissue Engineering at the National Research Nuclear University MEPhI, told Izvestia about this on October 5.
To do this, a gene for a photosensitive protein, opsin, is injected into the cells. Under the influence of light, it opens ion channels in the cell membrane, allowing the generation of an electrical pulse.
"Optogenetics allows you to selectively activate cells of only a certain type, without affecting neighboring ones," Zakharova explained.
According to the expert, this approach has helped to identify neural circuits associated with memory, fear, hunger, thirst and social connections. In medicine, it can potentially be used to treat blindness and deafness, combat neurodegenerative diseases, and correct heart rhythm.
The MCO-010 therapy from Nanoscope Therapeutics, which is nearing completion of trials, suggests the introduction of an adeno-associated virus to deliver the multifunctional opsin gene to bipolar retinal cells of patients suffering from severe stages of repinitis or Stargardt's disease," the expert said.
As Zakharova explained, initially light-insensitive cells acquire the ability to respond to ordinary daylight. According to her, the recovery or improvement of vision achieved in patients has been maintained for almost three years.
Last year, the prize was awarded to scientists Mary Brankov, Fred Ramsdell and Simon Sakaguchi for studying immunity. The discoveries of the laureates have played an important role in the development of cancer and autoimmune disease treatments, as well as in improving the effectiveness of transplants. Some of these studies are already undergoing clinical trials.
Переведено сервисом «Яндекс Переводчик»